NCT04478019View on ClinicalTrials.gov

SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

July 7, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
COVID-19SARS-CoV 2
Interventions
DRUG

10% Povidone-iodine nasal decolonization swab plus 0.12% CHG oral rinse

2 swab sticks of 10% povidone-iodine in each nares and 0.12% CHG oral rinse

Trial Locations (1)

53705

University of Wisconsin-Madison, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT04478019 - SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding | Biotech Hunter | Biotech Hunter